Stay updated on Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, indicating a new revision of the page content. This reflects behind-the-scenes updates rather than changes to the study details or user-facing information.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedThe page's revision tag was bumped from v3.6.3 to v3.6.4, indicating a small update to the page metadata. No changes to the study details or text are reflected in this update.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page's revision tag has been updated to v3.6.3, replacing v3.6.2, indicating a small update to the page's versioning rather than substantive content changes.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision: v3.6.2 has been added as the page’s build/version indicator. The underlying study details and page structure remain unchanged.SummaryDifference0.1%

- Check70 days agoChange DetectedRecruitment status was updated to indicate no longer looking for participants, informing users that enrollment is closed. The page also adds new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) and makes a formatting change to the Intervention/Treatment heading, along with a revision update to v3.6.0.SummaryDifference0.5%

- Check77 days agoChange DetectedThe page shows a new Revision: v3.5.5, replacing the previous v3.5.4, indicating an updated page revision.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial page.